Endothelial Dysfunction and Subendothelial Monocyte Macrophages in Hypertension: Effect of Angiotensin Converting Enzyme Inhibition

Hypertension is associated with an impairment of endothelium-dependent relaxation. The angiotensin converting enzyme inhibitors captopril and cilazapril can prevent this endothelial dysfunction. We recently observed that long-term treatment with cilazapril could also prevent subendothelial infiltrat...

Full description

Saved in:
Bibliographic Details
Published inHypertension (Dallas, Tex. 1979) Vol. 18; no. 2; pp. 132 - 141
Main Authors Clozel, Martine, Kuhn, Herbert, Hefti, Fridolin, Baumgartner, Hans R
Format Journal Article
LanguageEnglish
Published Philadelphia, PA American Heart Association, Inc 01.08.1991
Hagerstown, MD Lippincott
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Hypertension is associated with an impairment of endothelium-dependent relaxation. The angiotensin converting enzyme inhibitors captopril and cilazapril can prevent this endothelial dysfunction. We recently observed that long-term treatment with cilazapril could also prevent subendothelial infiltration by mononuclear cells in spontaneously hypertensive rats. This prompted us to examine whether, in spontaneously hypertensive rats, endothelial dysfunction and subendothelial infiltration by mononuclear cells are associated. These cells were characterized as monocyte macrophages. Infiltration by monocyte macrophages was quantified by morphometry. Endothelial function was estimated by calculating serotonin ratio (maximal contraction to serotonin on isolated arterial rings with endothelium over maximal contraction on paired rings without endothelium). The regional distribution of endothelial dysfunction and subendothelial monocyte macrophages was similar. Both were maximal in the carotid artery, less in the aorta, and nonexistent in the renal artery. A 2-week treatment with cilazapril decreased both endothelial dysfunction (serotonin ratio decreased by 32%) and the number of subendothelial monocyte macrophages in the aorta, which decreased by 38%. We conclude that in spontaneously hypertensive rats, endothelial dysfunction and subendothelial monocyte macrophage infiltration are associated and that cilazapril can decrease both. The observation that angiotensin converting enzyme inhibitors affect subendothelial accumulation of monocyte macrophages may lead to a better understanding of the mechanism of action of this class of drugs.
AbstractList Hypertension is associated with an impairment of endothelium-dependent relaxation. The angiotensin converting enzyme inhibitors captopril and cilazapril can prevent this endothelial dysfunction. We recently observed that long-term treatment with cilazapril could also prevent subendothelial infiltration by mononuclear cells in spontaneously hypertensive rats. This prompted us to examine whether, in spontaneously hypertensive rats, endothelial dysfunction and subendothelial infiltration by mononuclear cells are associated. These cells were characterized as monocyte macrophages. Infiltration by monocyte macrophages was quantified by morphometry. Endothelial function was estimated by calculating serotonin ratio (maximal contraction to serotonin on isolated arterial rings with endothelium over maximal contraction on paired rings without endothelium). The regional distribution of endothelial dysfunction and subendothelial monocyte macrophages was similar. Both were maximal in the carotid artery, less in the aorta, and nonexistent in the renal artery. A 2-week treatment with cilazapril decreased both endothelial dysfunction (serotonin ratio decreased by 32%) and the number of subendothelial monocyte macrophages in the aorta, which decreased by 38%. We conclude that in spontaneously hypertensive rats, endothelial dysfunction and subendothelial monocyte macrophage infiltration are associated and that cilazapril can decrease both. The observation that angiotensin converting enzyme inhibitors affect subendothelial accumulation of monocyte macrophage may lead to a better understanding of the mechanism of action of this class of drugs.
Hypertension is associated with an impairment of endothelium-dependent relaxation. The angiotensin converting enzyme inhibitors captopril and cilazapril can prevent this endothelial dysfunction. We recently observed that long-term treatment with cilazapril could also prevent subendothelial infiltration by mononuclear cells in spontaneously hypertensive rats. This prompted us to examine whether, in spontaneously hypertensive rats, endothelial dysfunction and subendothelial infiltration by mononuclear cells are associated. These cells were characterized as monocyte macrophages. Infiltration by monocyte macrophages was quantified by morphometry. Endothelial function was estimated by calculating serotonin ratio (maximal contraction to serotonin on isolated arterial rings with endothelium over maximal contraction on paired rings without endothelium). The regional distribution of endothelial dysfunction and subendothelial monocyte macrophages was similar. Both were maximal in the carotid artery, less in the aorta, and nonexistent in the renal artery. A 2-week treatment with cilazapril decreased both endothelial dysfunction (serotonin ratio decreased by 32%) and the number of subendothelial monocyte macrophages in the aorta, which decreased by 38%. We conclude that in spontaneously hypertensive rats, endothelial dysfunction and subendothelial monocyte macrophage infiltration are associated and that cilazapril can decrease both. The observation that angiotensin converting enzyme inhibitors affect subendothelial accumulation of monocyte macrophages may lead to a better understanding of the mechanism of action of this class of drugs.
Author Baumgartner, Hans R
Clozel, Martine
Kuhn, Herbert
Hefti, Fridolin
AuthorAffiliation Pharmaceutical Research Department, F. Hoffmann-La Roche Ltd, Basel, Switzerland
AuthorAffiliation_xml – name: Pharmaceutical Research Department, F. Hoffmann-La Roche Ltd, Basel, Switzerland
Author_xml – sequence: 1
  givenname: Martine
  surname: Clozel
  fullname: Clozel, Martine
  organization: Pharmaceutical Research Department, F. Hoffmann-La Roche Ltd, Basel, Switzerland
– sequence: 2
  givenname: Herbert
  surname: Kuhn
  fullname: Kuhn, Herbert
– sequence: 3
  givenname: Fridolin
  surname: Hefti
  fullname: Hefti, Fridolin
– sequence: 4
  givenname: Hans
  surname: Baumgartner
  middlename: R
  fullname: Baumgartner, Hans R
BackLink http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=4981508$$DView record in Pascal Francis
https://www.ncbi.nlm.nih.gov/pubmed/1653185$$D View this record in MEDLINE/PubMed
BookMark eNpNkM1v1DAQxS1UVLaFMyckHxC3pJ44Hza3alnYSq1AAiQ4WY4z3gSydhonVOHKP46XXQGn0cz7zYzeuyBnzjsk5DmwFKCEKwZpuwwpiDRLgWePyAqKLE_youRnZMVA5okE-PKEXITwjTHI87w6J-dQFhxEsSK_Nq7xU4t9p3v6Zgl2dmbqvKPaNfTjXON_8p133iwT0jttRj-0eoeBdo5ulwHHCV2Ie6_pxlo0E_WWXrtd5__MHV179yNCndvRjfu57JHeuLaru8Ovp-Sx1X3AZ6d6ST6_3Xxab5Pb9-9u1te3iSlKxhPZ8Fpwq2tuoCkRLUOheV3oEqWQrCo5cokWGWMGBGKFma6l5dZIMAI4vySvjneH0d_PGCa174LBvtcO_RxUlbEqK6GK4NURjDZDGNGqYez2elwUMHWIXTFQ268fFAiVqRh73HhxOj3Xe2z-8ceco_7ypOtgdG9H7UwX_mK5FFAwEbH8iD34fsIxfO_nBxxVi7qfWhWNsTwrRQJSAhOxSw4jzn8DxRufuQ
CODEN HPRTDN
CitedBy_id crossref_primary_10_1053_jvet_2001_20341
crossref_primary_10_1111_jphp_13363
crossref_primary_10_1161_01_CIR_101_13_1586
crossref_primary_10_1161_hy1101_093423
crossref_primary_10_1016_j_ejmech_2004_02_012
crossref_primary_10_1097_MBP_0b013e3282fed786
crossref_primary_10_1016_j_clinbiochem_2008_09_118
crossref_primary_10_12659_MSM_882622
crossref_primary_10_1016_0033_0620_92_90006_L
crossref_primary_10_1177_14703203010020011301
crossref_primary_10_1161_01_HYP_28_2_153
crossref_primary_10_1161_01_RES_80_6_838
crossref_primary_10_1016_j_compbiomed_2023_107686
crossref_primary_10_1152_ajpheart_2001_281_2_H655
crossref_primary_10_4161_cbt_25092
crossref_primary_10_1016_j_numecd_2006_05_001
crossref_primary_10_1007_BF02018860
crossref_primary_10_1093_eurheartj_ehy881
crossref_primary_10_1046_j_1538_7836_2003_00455_x
crossref_primary_10_1002_clc_4960240605
crossref_primary_10_1097_00005344_199608000_00016
crossref_primary_10_1161_01_HYP_26_5_744
crossref_primary_10_1111_j_1464_410X_2007_07035_x
crossref_primary_10_1161_01_ATV_18_9_1408
crossref_primary_10_4065_74_5_503
crossref_primary_10_1097_00005344_199903000_00001
crossref_primary_10_1155_2013_759103
crossref_primary_10_1177_000331970405500212
crossref_primary_10_3109_10641963_2014_960974
crossref_primary_10_1161_01_HYP_32_1_25
crossref_primary_10_1007_BF00051113
crossref_primary_10_1161_ATVBAHA_115_305377
crossref_primary_10_1161_01_HYP_30_6_1397
crossref_primary_10_1016_0735_1097_93_90340_7
crossref_primary_10_1016_j_trsl_2020_11_002
crossref_primary_10_1039_D1FO04446J
crossref_primary_10_1016_j_mehy_2004_10_016
crossref_primary_10_3109_08037059509077622
crossref_primary_10_1006_phrs_1999_0606
crossref_primary_10_1161_01_CIR_100_9_940
crossref_primary_10_26442_2075082X_2020_200214
crossref_primary_10_1084_jem_20070657
crossref_primary_10_1177_1470320317706653
crossref_primary_10_1161_01_HYP_34_4_546
crossref_primary_10_1111_j_1476_5381_1992_tb13426_x
crossref_primary_10_1161_01_HYP_27_3_371
crossref_primary_10_1152_ajpheart_00585_2013
crossref_primary_10_1161_01_HYP_34_1_113
crossref_primary_10_1111_j_1538_7836_2005_01240_x
crossref_primary_10_1016_S1357_2725_02_00271_6
crossref_primary_10_1016_S0025_7753_03_73706_3
crossref_primary_10_1152_ajpheart_00283_2015
crossref_primary_10_1097_00000441_199809000_00002
crossref_primary_10_1016_S0895_7061_99_00169_7
crossref_primary_10_1097_01_fjc_0000167009_90553_91
crossref_primary_10_1161_01_HYP_30_1_134
crossref_primary_10_1161_01_HYP_35_5_1055
crossref_primary_10_1016_j_mehy_2004_06_017
crossref_primary_10_3109_10641969409068588
crossref_primary_10_1161_01_HYP_25_2_194
crossref_primary_10_1161_01_HYP_37_2_414
crossref_primary_10_1097_HJH_0b013e3282f6a65e
crossref_primary_10_1097_00041552_200105000_00005
crossref_primary_10_1161_01_CIR_100_11_1223
crossref_primary_10_1038_hr_2014_132
crossref_primary_10_1161_01_HYP_26_1_118
crossref_primary_10_1097_00005344_199905000_00012
crossref_primary_10_1016_j_ejphar_2005_10_011
crossref_primary_10_1042_CS20201372
crossref_primary_10_1097_00005344_199811000_00017
crossref_primary_10_1097_00005344_200109011_00002
crossref_primary_10_1161_01_RES_81_5_804
crossref_primary_10_1093_ckj_sfad059
crossref_primary_10_1111_j_1748_1716_2007_01737_x
crossref_primary_10_1161_01_CIR_91_4_1129
crossref_primary_10_3109_08923979409007094
crossref_primary_10_1111_j_1474_8673_1993_tb00264_x
crossref_primary_10_1007_BF00400718
crossref_primary_10_1016_0014_2999_96_00392_5
crossref_primary_10_1016_S0163_7258_97_00051_X
crossref_primary_10_1007_BF02253425
crossref_primary_10_1097_00004872_200204000_00010
crossref_primary_10_1161_01_RES_80_1_45
crossref_primary_10_1152_ajpheart_00825_2012
crossref_primary_10_3389_fimmu_2022_852115
crossref_primary_10_1007_s10753_015_0146_9
crossref_primary_10_3317_jraas_2005_016
crossref_primary_10_1177_000331979905000101
crossref_primary_10_1002_ddr_430290206
crossref_primary_10_1038_sj_bjp_0705557
crossref_primary_10_1016_j_jim_2013_07_009
crossref_primary_10_1097_00029330_200607020_00016
crossref_primary_10_1097_00005344_199601000_00016
crossref_primary_10_1152_ajpregu_00259_2017
crossref_primary_10_1097_00005344_199601000_00011
crossref_primary_10_1016_S0002_8703_97_70007_3
crossref_primary_10_1007_s11906_999_0079_5
crossref_primary_10_1097_00004872_200104000_00011
crossref_primary_10_1111_j_1440_1681_1998_tb02245_x
crossref_primary_10_1161_01_RES_86_12_1266
crossref_primary_10_1016_j_lfs_2020_118436
crossref_primary_10_1016_S0025_7125_05_70571_X
crossref_primary_10_1161_01_HYP_25_6_1306
crossref_primary_10_1016_S0002_9629_15_40395_7
crossref_primary_10_1016_S0167_5273_03_00198_0
crossref_primary_10_1097_00004872_200411000_00020
crossref_primary_10_1016_S0002_9149_96_00526_7
crossref_primary_10_1161_01_HYP_36_3_360
crossref_primary_10_1016_S0735_1097_98_00099_0
crossref_primary_10_1016_S1042_3680_18_30642_9
crossref_primary_10_1016_S0014_2999_02_02046_0
crossref_primary_10_1177_107424849800300207
crossref_primary_10_1007_BF00986228
crossref_primary_10_1161_01_RES_83_9_952
crossref_primary_10_1016_j_ejphar_2006_04_014
crossref_primary_10_1111_bph_14389
crossref_primary_10_1016_S0021_9150_98_00309_8
crossref_primary_10_1016_S0025_6196_11_65132_X
crossref_primary_10_1152_ajplung_00047_2008
ContentType Journal Article
Copyright 1991 American Heart Association, Inc.
1992 INIST-CNRS
Copyright_xml – notice: 1991 American Heart Association, Inc.
– notice: 1992 INIST-CNRS
DBID IQODW
CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
7X8
DOI 10.1161/01.hyp.18.2.132
DatabaseName Pascal-Francis
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
CrossRef
MEDLINE - Academic
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
CrossRef
MEDLINE - Academic
DatabaseTitleList MEDLINE - Academic
CrossRef
MEDLINE

Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1524-4563
EndPage 141
ExternalDocumentID 10_1161_01_HYP_18_2_132
1653185
4981508
00004268-199108000-00003
Genre Journal Article
GroupedDBID -
.XZ
.Z2
01R
08R
0R
1J1
2WC
3O-
40H
4Q1
4Q2
4Q3
53G
55
5GY
5RE
5VS
71W
77Y
7O
7O~
AAAXR
AAMOA
AAMTA
AAPBV
AARTV
AAXQO
AAYEP
ABBUW
ABFLS
ABOCM
ABXVJ
ABZAD
ACDDN
ACEWG
ACGFS
ACWDW
ACWRI
ACXNZ
ADBBV
ADFPA
ADNKB
AE3
AENEX
AFFNX
AFUWQ
AHMBA
AHULI
AHVBC
AIJEX
AJIOK
AJNYG
AJYGW
ALMA_UNASSIGNED_HOLDINGS
AMJPA
ASCII
AWKKM
BAWUL
BOYCO
BQLVK
C1A
C45
CS3
DIK
DUNZO
E.X
E3Z
EBS
EJD
EX3
F2K
F2L
F2M
F2N
F5P
FL-
FW0
GJ
GX1
H0
H0~
H13
HZ
IKYAY
IN
IN~
JF9
JG8
JK3
JK8
K8S
KD2
KMI
KQ8
L-C
L7B
LI0
N9A
N~7
N~B
N~M
O0-
O9-
OAG
OAH
OB3
OCUKA
ODA
OGROG
OHASI
OK1
OL1
OLG
OLH
OLU
OLV
OLW
OLY
OLZ
OPUJH
ORVUJ
OUVQU
OVD
OVDNE
OVIDH
OVLEI
OWW
OWY
OXXIT
P-K
P2P
PQEST
PQQKQ
R58
RAH
RHF
RIG
RLZ
RSW
S4R
S4S
V2I
WH7
WOQ
WOW
X3V
X3W
X7M
XZ
YHZ
Z2
ZA5
ZGI
---
.-D
.3C
.55
.GJ
0R~
18M
AAFWJ
AAGIX
AAHPQ
AAJCS
AAQKA
AASOK
AAUGY
ABASU
ABDIG
ABQRW
ACCJW
ACGFO
ACILI
ADGGA
AE6
AEBDS
AEETU
AFDTB
AGINI
AHOMT
AHRYX
AJNWD
AKALU
AKULP
ALMTX
AMKUR
AMNEI
AOHHW
BCGUY
BS7
DIWNM
EEVPB
FCALG
GNXGY
GQDEL
HZ~
IKREB
IPNFZ
IQODW
K-A
K-F
N4W
ODMTH
OHYEH
OJAPA
OWBYB
OWU
OWV
OWX
OWZ
T8P
TEORI
TR2
TSPGW
VVN
W3M
W8F
XXN
XYM
YFH
YOC
YYM
YYP
ZFV
ZZMQN
AAAAV
AAIQE
AASCR
ABJNI
ABVCZ
ACXJB
ADHPY
AFEXH
AHQNM
AINUH
CGR
CUY
CVF
ECM
EIF
ERAAH
HLJTE
NPM
AAYXX
AJZMW
CITATION
7X8
ID FETCH-LOGICAL-c5603-9d3b83fab3c1d6eef0e8a3b5a6e9890763e39efe000c18ee7e2ab9f3fc91c8133
ISSN 0194-911X
IngestDate Wed Sep 25 09:39:49 EDT 2024
Fri Aug 23 04:05:38 EDT 2024
Thu May 23 23:55:40 EDT 2024
Sun Oct 29 17:06:31 EDT 2023
Thu Aug 13 19:45:01 EDT 2020
IsDoiOpenAccess false
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 2
Keywords Hypertension
Rat
Enzyme
Rodentia
Enzyme inhibitor
Cardiovascular disease
Artery
Endothelium
Vertebrata
Chemotherapy
Mammalia
Treatment
Animal
Angiotensin converting enzyme
Antihypertensive agent
Infiltration
Hemodynamics
Macrophage
Language English
License CC BY 4.0
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c5603-9d3b83fab3c1d6eef0e8a3b5a6e9890763e39efe000c18ee7e2ab9f3fc91c8133
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
OpenAccessLink https://doi.org/10.1161/01.hyp.18.2.132
PMID 1653185
PQID 72072617
PQPubID 23479
PageCount 10
ParticipantIDs proquest_miscellaneous_72072617
crossref_primary_10_1161_01_HYP_18_2_132
pubmed_primary_1653185
pascalfrancis_primary_4981508
wolterskluwer_health_00004268-199108000-00003
ProviderPackageCode L-C
C45
7O~
AARTV
ADFPA
OLH
ASCII
OLG
AAMOA
ODA
ABZAD
ABBUW
JK3
ADNKB
JK8
H0~
1J1
OLV
OLU
JG8
OLW
OLZ
OLY
F2K
F2M
F2L
F2N
OHASI
AHVBC
AJNYG
FL-
KMI
K8S
OGROG
OVLEI
AJIOK
OPUJH
V2I
.XZ
S4R
S4S
4Q1
DUNZO
OAG
4Q2
OVDNE
4Q3
AMJPA
OAH
OVD
71W
AHULI
ACEWG
OB3
.Z2
N~7
IKYAY
OVIDH
AWKKM
40H
N~B
OUVQU
ORVUJ
X3V
X3W
ACDDN
ACWRI
BOYCO
AIJEX
AAXQO
AAMTA
AAAXR
E.X
OWW
OCUKA
OWY
01R
ACXNZ
OL1
ABXVJ
IN~
KD2
OXXIT
77Y
ACWDW
JF9
FW0
PublicationCentury 1900
PublicationDate 1991-August
PublicationDateYYYYMMDD 1991-08-01
PublicationDate_xml – month: 08
  year: 1991
  text: 1991-August
PublicationDecade 1990
PublicationPlace Philadelphia, PA
Hagerstown, MD
PublicationPlace_xml – name: Philadelphia, PA
– name: Hagerstown, MD
– name: United States
PublicationTitle Hypertension (Dallas, Tex. 1979)
PublicationTitleAlternate Hypertension
PublicationYear 1991
Publisher American Heart Association, Inc
Lippincott
Publisher_xml – name: American Heart Association, Inc
– name: Lippincott
SSID ssj0014447
Score 1.8078357
Snippet Hypertension is associated with an impairment of endothelium-dependent relaxation. The angiotensin converting enzyme inhibitors captopril and cilazapril can...
SourceID proquest
crossref
pubmed
pascalfrancis
wolterskluwer
SourceType Aggregation Database
Index Database
Publisher
StartPage 132
SubjectTerms Acetylcholine - pharmacology
Angiotensin-Converting Enzyme Inhibitors - pharmacology
Animals
Antihypertensive agents
Aorta - drug effects
Aorta - pathology
Biological and medical sciences
Captopril - pharmacology
Cardiovascular system
Carotid Arteries - drug effects
Carotid Arteries - pathology
Cell Movement - drug effects
Cilazapril
Dose-Response Relationship, Drug
Endothelium, Vascular - pathology
Endothelium, Vascular - physiopathology
Hypertension - drug therapy
Hypertension - physiopathology
Macrophages - physiology
Male
Medical sciences
Norepinephrine - pharmacology
Peptidyl-Dipeptidase A - physiology
Pharmacology. Drug treatments
Pyridazines - pharmacology
Rats
Rats, Inbred SHR
Rats, Inbred WKY
Renal Artery - drug effects
Renal Artery - pathology
Serotonin - pharmacology
Vasoconstriction - drug effects
Vasodilation - drug effects
Title Endothelial Dysfunction and Subendothelial Monocyte Macrophages in Hypertension: Effect of Angiotensin Converting Enzyme Inhibition
URI http://ovidsp.ovid.com/ovidweb.cgi?T=JS&NEWS=n&CSC=Y&PAGE=fulltext&D=ovft&AN=00004268-199108000-00003
https://www.ncbi.nlm.nih.gov/pubmed/1653185
https://search.proquest.com/docview/72072617
Volume 18
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1bb9MwFLbKEGgSQtwmCgz8wANSlRLHufkRxlDFNATSJpWnyE7stmJNqrYRtK_8CX4ux7GbyygS8BJVjmWn_r74nON8x0boZZyBmWZCOGkWKMfXm8-KNIocHsuU-0RRynQ28vnHcHTpfxgH417vZ0u1VK7FMN3uzSv5H1ShDHDVWbL_gGzdKBTAb8AXroAwXP8K49M80wlUV3rVO9ustI1a7-TFq1LI1m14piLdrLVcVR_aNeWTSok1mEIcuqxU7PDQA7uXsdYG5JNZUZXnRpm-rPTRMt9u5nqfkelMzGpMrXM7arWlPdd3epHeyJDk9-GAsIi1Fh5OroqtkQjUiz9n5TTvJkxIZeQGtf74LS_nExgKm6czsoLHzCbykVo1Vy9lAi9gqh0bS2SnX893wKWj--fnOkw2ky0xK6O_G4GQVIkNQxjCIYmH3vBaTUBxMa84QcJAp483xrCWKNo7N9BNL2KBDuvPPjffp3zft4n45j_YTaOg59fX-j1Et2xTHc_nzoKv4CVU5vSUfeEN1PlWaMXE6muVMNFyey7uobs2XsFvDPnuo57MH6Db51aR8RD9aHEQtziIgYO4y0G84yBucRDPctzhIDYcxIXCLQ7ihoPYcBA3HHyELt-fXpyMHHuwh5OCg00dllERU8UFTUkWSqlcGXMqAh5KFjMXTJ6kTCoJ5jolsZSR9LhgiqqUkTQmlB6hg7zI5WOEeaa4Djl4ELl-GvsiyDgFu5WlInIVp330ajfoycLs35JUcW9IEpckoy-fEhInXgJI9dFxB5S6vs9ifWpCH73YgZTAHKw_rPFcFuUqiTw30icb9NGRwa7pykDfR04Hy8QkOSdVhO6FsZZ7abGv2eXBpU_-1NBTdNi8S8_QwXpZymPwitfieUXQX_HWueA
link.rule.ids 315,786,790,27957,27958
linkProvider Colorado Alliance of Research Libraries
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Endothelial+dysfunction+and+subendothelial+monocyte+macrophages+in+hypertension.+Effect+of+angiotensin+converting+enzyme+inhibition&rft.jtitle=Hypertension+%28Dallas%2C+Tex.+1979%29&rft.au=Clozel%2C+M&rft.au=Kuhn%2C+H&rft.au=Hefti%2C+F&rft.au=Baumgartner%2C+H+R&rft.date=1991-08-01&rft.issn=0194-911X&rft.eissn=1524-4563&rft.volume=18&rft.issue=2&rft.spage=132&rft_id=info:doi/10.1161%2F01.hyp.18.2.132&rft_id=info%3Apmid%2F1653185&rft.externalDocID=1653185
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0194-911X&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0194-911X&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0194-911X&client=summon